tiprankstipranks
Advertisement
Advertisement

DRMA Stock Latest News

Dermata Therapeutics announces Tome Foundational Treatment open to preorders
The FlyDermata Therapeutics announces Tome Foundational Treatment open to preorders
2d ago
DRMA
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot
PremiumCompany Announcements
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot
6d ago
8K
DRMA
Dermata Therapeutics prices 2.29M shares at $1.46 in private placement
PremiumThe Fly
Dermata Therapeutics prices 2.29M shares at $1.46 in private placement
6d ago
DRMA
Dermata Therapeutics Launches Tome Foundational Skincare Line
PremiumCompany Announcements
Dermata Therapeutics Launches Tome Foundational Skincare Line
18d ago
8K
DRMA
Dermata to commercially launch Tome Foundational Treatment on August 25
PremiumThe Fly
Dermata to commercially launch Tome Foundational Treatment on August 25
18d ago
DRMA
Dermata Therapeutics Shareholders Approve Equity Plan and Directors
PremiumCompany AnnouncementsDermata Therapeutics Shareholders Approve Equity Plan and Directors
3M ago
8K
DRMA
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
Premium
Ratings
Analyst Reiterates Buy on Dermata, Keeps 12-Month Price Target Unchanged at $4
3M ago
DRMA
Dermata receives notice of acceptance of Australian patent application
Premium
The Fly
Dermata receives notice of acceptance of Australian patent application
5M ago
DRMA
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
PremiumThe Fly
Dermata Therapeutics price target lowered to $4 from $10 at Maxim
5M ago
DRMA
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
PremiumThe Fly
Dermata Therapeutics appoints Kyra Peckaitis as VP, marketing
6M ago
DRMA
Dermata Therapeutics announces release of Tome Skincare
PremiumThe Fly
Dermata Therapeutics announces release of Tome Skincare
6M ago
DRMA
Dermata Therapeutics Announces Board Resignation and Size Reduction
PremiumCompany Announcements
Dermata Therapeutics Announces Board Resignation and Size Reduction
6M ago
8K
DRMA
Dermata Therapeutics Expands At-The-Market Equity Offering Capacity
PremiumCompany AnnouncementsDermata Therapeutics Expands At-The-Market Equity Offering Capacity
7M ago
8K
DRMA
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
Premium
The Fly
Dermata Therapeutics files to sell 1.48M shares of common stock for holders
7M ago
DRMA
Dermata Therapeutics receives notice of grant of patent for acne treatment
Premium
The Fly
Dermata Therapeutics receives notice of grant of patent for acne treatment
7M ago
DRMA
Dermata Therapeutics Raises Capital via December Private Placement
PremiumCompany Announcements
Dermata Therapeutics Raises Capital via December Private Placement
8M ago
8K
DRMA
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
PremiumThe Fly
Dermata Therapeutics prices 2.02M shares at $2.04 in private placement
8M ago
DRMA
Dermata Therapeutics to reveal brand name for OTC skincare business
PremiumThe Fly
Dermata Therapeutics to reveal brand name for OTC skincare business
9M ago
DRMA
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
PremiumRatings
Dermata Therapeutics: Strategic Shift and Financial Stability Support Buy Rating
9M ago
DRMA
Dermata Therapeutics files $100M mixed securities shelf
PremiumThe FlyDermata Therapeutics files $100M mixed securities shelf
9M ago
DRMA
Dermata Therapeutics Ends License Agreement with Villani
Premium
Company Announcements
Dermata Therapeutics Ends License Agreement with Villani
9M ago
8K
DRMA
Dermata Therapeutics Shifts Focus to OTC Skincare
Premium
Company Announcements
Dermata Therapeutics Shifts Focus to OTC Skincare
9M ago
8K
DRMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >